(Q46694299)

24 December 2017

review article

1 reference

title

Effects of inhaled corticosteroids on the consequences of asthma (English)

1 reference

24 December 2017

0 references

Boushey HA

1

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

24 December 2017

The Journal of Allergy and Clinical Immunology

published in

1 reference

24 December 2017

volume

102

1 reference

24 December 2017

page(s)

S5-16

1 reference

24 December 2017

issue

4 Pt 2

1 reference

24 December 2017

Total population survey of the frequency and severity of asthma in 17 year old boys in an urban area in Israel

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

A national estimate of the economic costs of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Deaths from asthma in Victoria: a 12-month survey

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Pediatric asthma deaths in Victoria: the mild are at risk

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Aerosol beclomethasone dipropionate in chronic bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Substitution of beclomethasone aerosol for oral prednisolone in the treatment of chronic asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Steroid-dependent asthma treated with inhaled beclomethasone dipropionate. A long-term study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Work disability among adults with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Measuring quality of life in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

A scale for the measurement of quality of life in adults with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Asthma and irreversible airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Asthma in the elderly. A comparison between patients with recently acquired and long-standing disease

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

A case-control study of deaths from asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Mortality and markers of risk of asthma death among 1,075 outpatients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Airways remodeling is a distinctive feature of asthma and is related to severity of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Damage of the airway epithelium and bronchial reactivity in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Mucosal inflammation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

The pathology of asthma, with special reference to changes in the bronchial mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Effect of nitrogen dioxide and sulphur dioxide on airway response of mild asthmatic patients to allergen inhalation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

The effect of ozone exposure on allergen responsiveness in subjects with asthma or rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

The role of respiratory infections in airway hyperresponsiveness and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Treatment of childhood asthma for 13 months and longer with beclomethasone dipropionate aerosol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Control of asthma with triamcinolone acetonide aerosol inhalations at 12-hour intervals

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Efficacy and safety of triamcinolone acetonide aerosol in chronic asthma. Results of a multicenter, short-term controlled and long-term open study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

The effect of two months of treatment with inhaled budesonide on bronchial responsiveness to histamine and house-dust mite antigen in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Short-term double-blind evaluation of flunisolide aerosol for steroid-dependent asthmatic children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Fluticasone propionate in children with moderate asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Effectiveness of prophylactic inhaled steroids in childhood asthma: a systemic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Measuring health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Impact of fluticasone propionate powder on health-related quality of life in patients with moderate asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Risk factors for recurrent emergency department visits for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Community study of role of viral infections in exacerbations of asthma in 9-11 year old children

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Oral prednisone therapy in experimental rhinovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Decrease in hospitalization for treatment of childhood asthma with increased use of antiinflammatory treatment, despite an increase in prevalence of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Inhaled steroids and the risk of hospitalization for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Markers of Risk of Asthma Death or Readmission in the 12 Months Following a Hospital Admission for Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Asthma: analysis of sudden deaths and ventilatory arrests in hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Sudden death in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

The pathogenesis of severe asthma: A consensus report from the workshop on pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Longitudinal study of near fatal asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

High-dose beclomethasone inhaler in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

The place of high-dose inhaled corticosteroids in asthma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Comparison of oral-steroid sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Response of patients receiving high dose beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Dose-ranging study of the clinical efficacy of twice-daily triamcinolone acetonide inhalation aerosol in moderately severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Budesonide treatment of moderate and severe asthma in children: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Airway inflammation in mild intermittent and in persistent asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Functional characteristics of bronchial epithelium obtained by brushing from asthmatic and normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Eosinophilic Inflammation in Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Perception of bronchial obstruction in asthmatic patients. Relationship with bronchial eosinophilic inflammation and epithelial damage and effect of corticosteroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Effect of inhaled beclomethasone dipropionate on expression of proinflammatory cytokines and activated eosinophils in the bronchial epithelium of patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Effect of 1 year daily treatment with 400 microg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthmatics.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Meta-analysis of controlled trials of drug therapy in mild chronic asthma: the role of inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

The combined use of betamethasone valerate and sodium cromoglycate in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Betamethasone valerate compared with sodium cromoglycate in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Treating Mild Asthma -- When Are Inhaled Steroids Indicated?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Short-term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Growth and childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

A meta-analysis of the effect of oral and inhaled corticosteroids on growth

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Use of inhaled corticosteroids and the risk of cataracts.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Features of asthma in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

A prospective study of asthma in a rural community

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Mortality and decline in lung function in 213 adults with bronchial asthma: a ten-year follow up

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Computed tomography of the lungs in asthma: influence of disease severity and etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Effect of early vs late intervention with inhaled corticosteroids in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Is delayed introduction of inhaled corticosteroids harmful in patients with obstructive airways disease (asthma and COPD)? The Dutch CNSLD Study Group. The Dutch Chronic Nonspecific Lung Disease Study Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Respiratory symptoms in young adults should not be overlooked.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Natural history of childhood asthma. 20-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

The natural history of childhood asthma to adult life

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Childhood asthma in adult life: a further study at 28 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

A prospective study of the natural history of asthma. Remission and relapse rates

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Adult patients may outgrow their asthma: a 25-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Reduction of budesonide after a year of increased use: a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Can steroids cause asthma to remit?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Remission of childhood asthma after long-term treatment with an inhaled corticosteroid (budesonide): can it be achieved? Dutch CNSLD Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970001-6

7 January 2021

10.1016/S0091-6749(98)70001-6

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

9798719

1 reference

24 December 2017